Reassessment of ATC-groups C01, C04 and C05

At its meeting on 19 September 2006 , the Reimbursement Committee had its first discussion of the reimbursement status of the following ATC groups:

• Medicinal products for cardiac therapy (C01)
• Peripheral vasodilators (C04)
• Vasoprotectives (C05)

In the fact box to your right, you can find a link to the documents from the Reimbursement Committee meetings (in Danish only).

For further information, please contact the Reimbursement Department, medicintilskud@dkma.dk.

The Danish Medicines Agency, 6 October 2006